AEON Biopharma, Inc. (AEON) vs Pluri Inc. (PLUR)
AEON Biopharma, Inc. and Pluri Inc. are both Biotechnology companies. AEON Biopharma, Inc. and Pluri Inc. are of similar size ($13.0M and $12.7M). AEON Biopharma, Inc. has the higher net margin (0.00% vs −2,344.6%) and the higher return on invested capital (0.00% vs −526.9%). Across the 12 metrics below, AEON Biopharma, Inc. leads on 8 and Pluri Inc. on 4.
Valuation
Profitability
| Metric | AEON | PLUR | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 44.59% | 65.16% |
| Operating margin | 0.00% | (2,454.53%) | 0.00% |
| Net margin | 0.00% | (2,344.59%) | 0.00% |
| Free cash flow margin | 0.00% | (1,988.48%) | 0.00% |
| Return on equity | 350.00% | 260.35% | (57.72%) |
| Return on assets | (621.70%) | (74.95%) | (49.22%) |
| Return on invested capital | 0.00% | (526.92%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack